Key result
NS-1619 improves LVP and reduces infarct size ~2.5-fold in isolated guinea pig hearts.
Population
Isolated guinea pig hearts
Comparison
BK channel opener NS-1619 given for 15 min… vs Control or NS-1619 combined with MnTBAP or…
Design
Preclinical
Authors
Loading...
BK(Ca) channel opening is hypothesis-generating for cardioprotection in preclinical models; should not yet influence clinical practice.
Effect estimate: 2.5-fold increase in developed LVP and 2.5-fold decrease in infarct size
Pharmacological opening of the BK(Ca) channel induces mitochondrial preconditioning and protects against ischemia-reperfusion injury via a ROS-dependent mechanism.
Stowe et al. (2005) studied Ischemia-reperfusion (I/R) injury. BK(Ca) channel opener NS-1619 vs. Control / antagonists (MnTBAP or paxilline) was evaluated on Left ventricular pressure and infarct size (2.5-fold increase in developed LVP and 2.5-fold decrease in infarct size). Pretreatment with the BK(Ca) channel opener NS-1619 resulted in a 2.5-fold increase in developed left ventricular pressure and a 2.5-fold decrease in infarct size in isolated guinea pig hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: